Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:affects |
adults
children pregnant women cerebral veins dural venous sinuses |
| gptkbp:alsoKnownAs |
gptkb:CVT
|
| gptkbp:associatedWith |
gptkb:sinusitis
gptkb:systemic_lupus_erythematosus gptkb:antiphospholipid_syndrome gptkb:vaccine-induced_immune_thrombotic_thrombocytopenia dehydration COVID-19 infection nephrotic syndrome inflammatory bowel disease otitis media mastoiditis head and neck infections |
| gptkbp:cause |
coma
visual disturbances papilledema |
| gptkbp:complication |
stroke
intracerebral hemorrhage increased intracranial pressure |
| gptkbp:diagnosedBy |
MRI
CT venography MR venography |
| gptkbp:firstDescribed |
1825
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cerebral Venous Thrombosis
|
| gptkbp:ICD-10_code |
I67.6
|
| gptkbp:mortalityRate |
5-10%
|
| gptkbp:prognosis |
generally good with early treatment
|
| gptkbp:riskFactor |
gptkb:trauma
infection pregnancy oral contraceptive use malignancy thrombophilia |
| gptkbp:symptom |
headache
seizures altered mental status focal neurological deficits |
| gptkbp:treatment |
gptkb:warfarin
gptkb:heparin anticoagulation |
| gptkbp:bfsParent |
gptkb:CVT
|
| gptkbp:bfsLayer |
5
|